ACH
AERI

ArrowMark Colorado Holdings’s Aerie Pharmaceuticals AERI Stock Holding History

ArrowMark Colorado Holdings’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-278
Closed -$10K – 469
2016
Q3 		$10K Buy
+278
New +$6.13K ﹤0.01% 333

Other funds holding AERI

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ArrowMark Colorado Holdings's AERI Position: Q4 2016 in Review

ArrowMark Colorado Holdings sold out of Aerie Pharmaceuticals (AERI) in Q4 2016, closing a stake of 278 shares — an estimated $10K sold.

ArrowMark Colorado Holdings first reported a position in AERI in Q3 2016 and held it in 1 quarter. The position peaked at $10K in Q3 2016. 151 funds tracked by Wall St. Rank hold AERI as of Q4 2016.

  • ArrowMark Colorado Holdings reported no remaining Aerie Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 278 Aerie Pharmaceuticals shares in Q4 2016, an estimated $10K.
  • ArrowMark Colorado Holdings first reported a position in Aerie Pharmaceuticals in Q3 2016 and held it in 1 quarter.
  • ArrowMark Colorado Holdings's Aerie Pharmaceuticals position peaked at $10K in Q3 2016.
  • 151 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2016.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.